3TL0 image
Entry Detail
PDB ID:
3TL0
Title:
Structure of SHP2 N-SH2 domain in complex with RLNpYAQLWHR peptide
Biological Source:
Source Organism:
Host Organism:
PDB Version:
Deposition Date:
2011-08-29
Release Date:
2011-09-28
Method Details:
Experimental Method:
Resolution:
2.05 Å
R-Value Free:
0.23
R-Value Work:
0.19
R-Value Observed:
0.19
Space Group:
P 43 21 2
Macromolecular Entities
Polymer Type:polypeptide(L)
Description:Tyrosine-protein phosphatase non-receptor type 11
Chain IDs:A
Chain Length:109
Number of Molecules:1
Biological Source:Homo sapiens
Polymer Type:polypeptide(L)
Description:RLNpYAQLWHR peptide
Chain IDs:B
Chain Length:10
Number of Molecules:1
Biological Source:
Modified Residue
Compound ID Chain ID Parent Comp ID Details 2D Image
PTR B TYR O-PHOSPHOTYROSINE
Ligand Molecules
Primary Citation
Simultaneous binding of two peptidyl ligands by a SRC homology 2 domain.
Biochemistry 50 7637 7646 (2011)
PMID: 21800896 DOI: 10.1021/bi200439v

Abstact

Src homology 2 (SH2) domains mediate protein-protein interactions by recognizing phosphotyrosine (pY)-containing sequences of target proteins. In all of the SH2 domain-pY peptide interactions described to date, the SH2 domain binds to a single pY peptide. Here, determination of the cocrystal structure of the N-terminal SH2 domain of phosphatase SHP-2 bound to a class IV peptide (VIpYFVP) revealed a noncanonical 1:2 (protein-peptide) complex. The first peptide binds in a canonical manner with its pY side chain inserted in the usual binding pocket, while the second pairs up with the first to form two antiparallel β-strands that extend the central β-sheet of the SH2 domain. This unprecedented binding mode was confirmed in the solution phase by NMR experiments and shown to be adopted by pY peptides derived from cellular proteins. Site-directed mutagenesis and surface plasmon resonance studies revealed that the binding of the first peptide is pY-dependent, but phosphorylation is not required for the second peptide. Our findings suggest a potential new function for the SH2 domain as a molecular clamp to promote dimerization of signaling proteins.

Legend

Protein

Chemical

Disease

Primary Citation of related structures